Article
Peter Berger, MD, Chairman of Cardiology and Co-Director of the Geisinger Heart & Vascular Institute, Director, Cardiovascular Center for Clinical Research at Geisinger Clinic, thinks the biggest challenges that physicians face when treating patients with acute coronary syndrome is individualizing treatment for patients.
Peter Berger, MD, Chairman of Cardiology and Co-Director of the Geisinger Heart & Vascular Institute, Director, Cardiovascular Center for Clinical Research at Geisinger Clinic, thinks the biggest challenges that physicians face when treating patients with acute coronary syndrome is individualizing treatment for patients.
There are several anti-platelet agents with different strengths and weaknesses. It is important to figure out who should receive or avoid the most potent agents. Dr Berger says another very important thing physicians are struggling with is whether to use platelet reactivity data, or genetic information in determining what strength agent they need.
This video was taken at the American College of Cardiology's 62nd Annual Scientific Session & Expo in San Francisco, CA, on March 10, 2013.
The Importance of Examining and Preventing Atrial Fibrillation